- Home
- Life Sciences
- Pharmaceutical
- Pharmaceutical Analysis & Statistics in Canada, May 2013
Talk to Robyn
00 1 718 213 49 04
Search inside this page
Publication dates
Publishers
- Global Data (168)
- Euromonitor International (8)
- Global Markets Direct (148)
- Aruvian's R'search (2)
- Business Monitor International (318)
-
- Global Industry Analysts (1)
- Global Research & Data Services (10)
- ICD Research (17)
- Timely Data Resources Inc. (40)
- MarketLine (25)
- Global Industry Analyst (15)
- Datamonitor (13)
- Mintel (11)
- VacZine Analytics Group Of Assay Advantage Ltd (10)
- MarketLine Industry Guides (9)
- SCRIP Insights (7)
- World Market Intelligence Ltd (6)
- Business Review (5)
- Espicom Business Intelligence (4)
- ABMRG (3)
- GBI Research (3)
- Koncept Analytics (3)
- Life Science Analytics (LSA) (3)
- MarketsandMarkets (3)
- Barnes Reports (2)
- Obainfo (1)
- Apollo Managed Care Consultants (1)
- Arrowhead (1)
- Bioseeker (1)
- Canadean Ltd (1)
- DrugPatentWatch - ThinkBiotech LLC (1)
- Firstword Pharma (1)
- International Market Analysis Research and Consult (1)
- Ken Research Private (1)
- RNCOS (1)
- Visiongain (1)
All regions
- All
- North America
- Canada
data types
Free Market Research Guides to Download
Pharmaceutical Analysis & Statistics in Canada, May 2013
You might be interested in: therapeutics, cancer, drug, more »
» Purchase Premium Reports
1-40 of about 500 reports
PharmaPoint: Multiple Sclerosis - Canada Drug Forecast and Market Analysis to 2022
- $ 4 995
- Industry report
- March 2013
- by Global Data
PharmaPoint: Multiple Sclerosis - Canada Drug Forecast and Market Analysis to 2022 Summary GlobalData has released its new Country report, ?PharmaPoint: Multiple Sclerosis - Canada Drug Forecast and ...
- Industries : Pathology
- Countries : Canada
Global Herbal Supplements and Remedies Industry
- $ 4 950
- Industry report
- March 2013
- by Global Industry Analysts
This report analyzes the worldwide markets for Herbal Supplements and Remedies in US$ Million by the following Product Segments: Ginkgo Biloba, Garlic, Ginseng, Echinacea, St. John's Wort, Soy, Aloe Vera, ...
- Industries : Vitamin and Supplement
- Countries : World, Japan, United States, Canada, Europe, South America, North America, Asia, France, Germany, China, United Kingdom, Spain, Italy
Masitinib (Multiple Sclerosis) - Forecast and Market Analysis to 2022
- $ 3 495
- Industry report
- March 2013
- by Global Data
Masitinib (Multiple Sclerosis) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, ?Masitinib (Multiple Sclerosis) - Forecast and Market ...
- Industries : Pathology
- Countries : Canada, Spain, Italy, France, Germany, Japan, India, China, World, United States, Europe, United Kingdom
Siponimod (Multiple Sclerosis) - Forecast and Market Analysis to 2022
- $ 3 495
- Industry report
- March 2013
- by Global Data
Siponimod (Multiple Sclerosis) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, ?Siponimod (Multiple Sclerosis) - Forecast and Market ...
- Industries : Pathology
- Countries : Canada, Spain, Italy, France, Germany, Japan, India, China, World, United States, Europe, United Kingdom
Daclizumab (Multiple Sclerosis) - Forecast and Market Analysis to 2022
- $ 3 495
- Industry report
- March 2013
- by Global Data
Daclizumab (Multiple Sclerosis) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, ?Daclizumab (Multiple Sclerosis) - Forecast and Market ...
- Industries : Pathology
- Countries : Canada, Spain, Italy, France, Germany, Japan, India, China, World, United States, Europe, United Kingdom
Lemtrada (Multiple Sclerosis) - Forecast and Market Analysis to 2022
- $ 3 495
- Industry report
- March 2013
- by Global Data
Lemtrada (Multiple Sclerosis) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, ?Lemtrada (Multiple Sclerosis) - Forecast and Market ...
- Industries : Pathology
- Countries : United States, Canada, Spain, Italy, France, Germany, Japan, India, China, World, Europe, United Kingdom
Laquinimod (Multiple Sclerosis) - Forecast and Market Analysis to 2022
- $ 3 495
- Industry report
- March 2013
- by Global Data
Laquinimod (Multiple Sclerosis) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, ?Laquinimod (Multiple Sclerosis) - Forecast and Market ...
- Industries : Pathology
- Countries : Canada, Spain, Italy, France, Germany, Japan, India, China, World, United States, Europe, United Kingdom
Ocrelizumab (Multiple Sclerosis) - Forecast and Market Analysis to 2022
- $ 3 495
- Industry report
- March 2013
- by Global Data
Ocrelizumab (Multiple Sclerosis) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, ?Ocrelizumab (Multiple Sclerosis) - Forecast and Market ...
- Industries : Pathology
- Countries : United States, Canada, Spain, Italy, France, Germany, Japan, India, China, World, Europe, United Kingdom
NU-100 (Multiple Sclerosis) - Forecast and Market Analysis to 2022
- $ 3 495
- Industry report
- March 2013
- by Global Data
NU-100 (Multiple Sclerosis) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, ?NU-100 (Multiple Sclerosis) - Forecast and Market Analysis ...
- Industries : Pathology
- Countries : United States, Canada, Spain, Italy, France, Germany, Japan, India, China, World, Europe, United Kingdom
Aubagio (Multiple Sclerosis) - Forecast and Market Analysis to 2022
- $ 3 495
- Industry report
- March 2013
- by Global Data
Aubagio (Multiple Sclerosis) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, ?Aubagio (Multiple Sclerosis) - Forecast and Market Analysis ...
- Industries : Pathology
- Countries : Canada, Spain, Italy, France, Germany, Japan, India, China, World, Europe, United States, United Kingdom
Rebif (Multiple Sclerosis) - Forecast and Market Analysis to 2022
- $ 3 495
- Industry report
- March 2013
- by Global Data
Rebif (Multiple Sclerosis) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, ?Rebif (Multiple Sclerosis) - Forecast and Market Analysis ...
- Industries : Pathology
- Countries : United States, Canada, Spain, Italy, France, Germany, Japan, India, China, World, Europe, United Kingdom
Gilenya (Multiple Sclerosis) - Forecast and Market Analysis to 2022
- $ 3 495
- Industry report
- March 2013
- by Global Data
Gilenya (Multiple Sclerosis) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, ?Gilenya (Multiple Sclerosis) - Forecast and Market Analysis ...
- Industries : Pathology
- Countries : Canada, Japan, World, United States, Spain, Italy, France, Germany, India, China, Europe, United Kingdom
Tysabri (Multiple Sclerosis) - Forecast and Market Analysis to 2022
- $ 3 495
- Industry report
- March 2013
- by Global Data
Tysabri (Multiple Sclerosis) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, ?Tysabri (Multiple Sclerosis) - Forecast and Market Analysis ...
- Industries : Pathology
- Countries : Canada, Spain, Italy, France, Germany, Japan, India, China, World, United States, Europe, United Kingdom
Betaseron/Betaferon (Multiple Sclerosis) - Forecast and Market Analysis to 2022
- $ 3 495
- Industry report
- March 2013
- by Global Data
Betaseron/Betaferon (Multiple Sclerosis) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, ?Betaseron/Betaferon (Multiple Sclerosis) ...
- Industries : Pathology
- Countries : World, United States, Canada, Spain, Italy, France, Germany, Japan, India, China, Europe, United Kingdom
Copaxone (Multiple Sclerosis) - Forecast and Market Analysis to 2022
- $ 3 495
- Industry report
- March 2013
- by Global Data
Copaxone (Multiple Sclerosis) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, ?Copaxone (Multiple Sclerosis) - Forecast and Market ...
- Industries : Pathology
- Countries : Canada, Spain, Italy, France, Germany, Japan, India, China, World, United States, Europe, United Kingdom
Avonex (Multiple Sclerosis) - Forecast and Market Analysis to 2022
- $ 3 495
- Industry report
- March 2013
- by Global Data
Avonex (Multiple Sclerosis) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, ?Avonex (Multiple Sclerosis) - Forecast and Market Analysis ...
- Industries : Pathology
- Countries : United States, Canada, Spain, Italy, France, Germany, Japan, India, China, World, Europe, United Kingdom
Relapsing Remitting Multiple Sclerosis (RRMS) - Pipeline Review, H1 2013
- $ 2 000
- Company report
- March 2013
- by Global Markets Direct
Relapsing Remitting Multiple Sclerosis (RRMS) - Pipeline Review, H1 2013 Summary Global Markets Direct's, 'Relapsing Remitting Multiple Sclerosis (RRMS) - Pipeline Review, H1 2013', provides an overview ...
- Industries : Pathology
- Countries : Canada, World
World Therapy: Rhinosinusitis - Pipeline Review, H1 2012
- $ 2 000
- Industry report
- February 2013
- by Global Markets Direct
This report provides data on the therapeutic development for Rhinosinusitis, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved ...
- Industries : Pathology
- Countries : World, Canada
Kidney Fibrosis - Pipeline Review, H1 2013
- $ 2 000
- Industry report
- February 2013
- by Global Markets Direct
Kidney Fibrosis - Pipeline Review, H1 2013 Summary Global Markets Direct's, 'Kidney Fibrosis - Pipeline Review, H1 2013', provides an overview of the indication's therapeutic pipeline. This report provides ...
- Industries : Therapy
- Countries : World, United States, Canada, Japan, China
World Pathology: Metastatic Lung Cancer - Pipeline Review, H1 2012
- $ 2 000
- Company report
- April 2013
- by Global Markets Direct
This report provides data on the therapeutic development for Metastatic Lung Cancer, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players ...
- Industries : Pathology
- Countries : World, United States, Canada
Other Dermatological Disorders - Pipeline Review, H1 2013
- $ 2 000
- Company report
- March 2013
- by Global Markets Direct
Other Dermatological Disorders - Pipeline Review, H1 2013 Summary Global Markets Direct's, 'Other Dermatological Disorders - Pipeline Review, H1 2013', provides an overview of the indication's therapeutic ...
- Industries : Therapy
- Countries : World, United States, Canada
Canada Pharmaceuticals and Healthcare Industry Update Quarter 2 2012
- $ 1 088
- Industry report
- February 2013
- by Business Monitor International
BMI View: With Canada's economy set to weather the external storm, the outlook for the country's pharmaceutical industry looks relatively stable. Over the longer-term an ageing population in this already ...
- Industries : Drug and Medication
- Countries : Canada
NRT Smoking Cessation Aids Market Analysis in Canada
- $ 898
- Industry report
- May 2013
- by Euromonitor International
This increase was due in large part to the combined efforts of anti-smoking organisations and government initiatives to curb smoking in Canada. Provinces across Canada have bans on smoking in public areas ...
- Industries : Tobacco, Pathology
- Countries : Canada
Vitamins and Dietary Supplements Market Analysis in Canada
- $ 898
- Industry report
- May 2013
- by Euromonitor International
Between 2006 and 2011, the number of Canadians over the age of 65 increased from 13% of the population to over 14% of the total population. Additionally, consumer surveys released in Canada indicate that ...
- Industries : Vitamin and Supplement
- Countries : Canada
Digestive Remedies Market Overview in Canada
- $ 898
- Industry report
- May 2013
- by Euromonitor International
Retail sales of digestive remedies registered a solid growth of 3%, reaching current value sales of C$363 million in 2010. The rapidly ageing population in Canada as well as rising incidence of indigestion ...
- Industries : Drug and Medication
- Countries : Canada
Analgesics Market Overview in Canada
- $ 898
- Industry report
- May 2013
- by Euromonitor International
Sales of analgesics continued to show strong growth of 4% in 2010, reaching C$766 million in current value terms. Growth was largely driven by Canada's rapidly ageing population as seniors increasingly ...
- Industries : Drug and Medication
- Countries : Canada
Cough, Cold and Allergy (Hay Fever) Remedies Market Analysis in Canada
- $ 898
- Industry report
- May 2013
- by Euromonitor International
Over nine million Canadians are said to suffer from allergies and are facing longer periods of discomfort. Studies have shown increases as drastic as a rise of 27 days over a 10-year period, 1995-2005, ...
- Industries : Drug and Medication
- Countries : Canada
Mitomics Inc. - Product Pipeline Analysis, 2013 Update
- $ 750
- Company report
- May 2013
- by Global Data
Summary Mitomics Inc. (Mitomics) is a medical diagnostic device manufacturing company. The company researches and develops mitochondrial genome-based products to improve clinical insight and therapeutic ...
- Industries : Pathology
- Countries : Canada
Caprion Inc. - Product Pipeline Analysis, 2013 Update
- $ 750
- Company report
- May 2013
- by Global Data
Summary Caprion Inc. (Caprion) is a biotechnology company. The company provides proteomics biomarker and target identification services. It offers services such as biomarker services, in-vitro diagnostics ...
- Industries : Pathology
- Countries : Canada
Vaccine Market in Canada
- $ 652
- Industry report
- May 2013
- by Global Research & Data Services
This market research report offers a perspective on the actual market situation, trends and future outlook for vaccines in Canada. The study provides essential market information for decision-makers including: ...
- Industries : Drug and Medication
- Countries : Canada
Canada Poisonings, 60-69 Yrs, Male, Dalys
- $ 250
- Industry data
- May 2013
Yearly, From 2005 To 2030
By Business Monitor International
Source: WHO, World Bank, IMF, BMI research
- Industries : Pharmaceutical
- Countries : Canada
Canada Poisonings, 70+ Yrs, Male, Dalys
- $ 250
- Industry data
- May 2013
Yearly, From 2005 To 2030
By Business Monitor International
Source: WHO, World Bank, IMF, BMI research
- Industries : Pharmaceutical
- Countries : Canada
Canada Poisonings, 15-29 Yrs, Female, Dalys
- $ 250
- Industry data
- May 2013
Yearly, From 2005 To 2030
By Business Monitor International
Source: WHO, World Bank, IMF, BMI research
- Industries : Pharmaceutical
- Countries : Canada
Canada Poisonings, 30-44 Yrs, Female, Dalys
- $ 250
- Industry data
- May 2013
Yearly, From 2005 To 2030
By Business Monitor International
Source: WHO, World Bank, IMF, BMI research
- Industries : Pharmaceutical
- Countries : Canada
Canada Poisonings, 45-59 Yrs, Male, Dalys
- $ 250
- Industry data
- May 2013
Yearly, From 2005 To 2030
By Business Monitor International
Source: WHO, World Bank, IMF, BMI research
- Industries : Pharmaceutical
- Countries : Canada
Canada Poisonings, 60-69 Yrs, Female, Dalys
- $ 250
- Industry data
- May 2013
Yearly, From 2005 To 2030
By Business Monitor International
Source: WHO, World Bank, IMF, BMI research
- Industries : Pharmaceutical
- Countries : Canada
Canada Poisonings, 0-4 Yrs, Female, Dalys
- $ 250
- Industry data
- May 2013
Yearly, From 2005 To 2030
By Business Monitor International
Source: WHO, World Bank, IMF, BMI research
- Industries : Pharmaceutical
- Countries : Canada
Canada Poisonings, 45-59 Yrs, Female, Dalys
- $ 250
- Industry data
- May 2013
Yearly, From 2005 To 2030
By Business Monitor International
Source: WHO, World Bank, IMF, BMI research
- Industries : Pharmaceutical
- Countries : Canada
Canada Poisonings, 70+ Yrs, Female, Dalys
- $ 250
- Industry data
- May 2013
Yearly, From 2005 To 2030
By Business Monitor International
Source: WHO, World Bank, IMF, BMI research
- Industries : Pharmaceutical
- Countries : Canada
Canada Poisonings, Total, Female, Dalys
- $ 250
- Industry data
- May 2013
Yearly, From 2005 To 2030
By Business Monitor International
Source: WHO, World Bank, IMF, BMI research
- Industries : Pharmaceutical
- Countries : Canada
» Download Public Reports
About 1 500 reports
Company Report: Cancer in Canada and The United States for Year 2013
- Company report
- April 2013
- 2 pages
... Terry fox: the feature film is the realization of a lifelong dream. Her father, an adidas executive, was the recipient of the letter that terry wrote to secure support of running shoes. Slattery says ...
» Read our Company Profiles
19 CompaniesGlaxoSmithKline P.L.C.
United StatesGlaxoSmithKline PLC
United KingdomJohnson and Johnson
United StatesAbbott Laboratories
United StatesSanofi-Aventis Senegal
SenegalReportlinker.com © Copyright 2013. All rights reserved.
